Your browser doesn't support javascript.
loading
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.
Bhardwaj, Nina; Friedlander, Philip A; Pavlick, Anna C; Ernstoff, Marc S; Gastman, Brian R; Hanks, Brent A; Curti, Brendan D; Albertini, Mark R; Luke, Jason J; Blazquez, Ana B; Balan, Sreekumar; Bedognetti, Davide; Beechem, Joseph M; Crocker, Andrea S; D'Amico, Leonard; Danaher, Patrick; Davis, Thomas A; Hawthorne, Thomas; Hess, Bruce W; Keler, Tibor; Lundgren, Lisa; Morishima, Chihiro; Ramchurren, Nirasha; Rinchai, Darawan; Salazar, Andres M; Salim, Bob A; Sharon, Elad; Vitale, Laura A; Wang, Ena; Warren, Sarah; Yellin, Michael J; Disis, Mary L; Cheever, Martin A; Fling, Steven P.
Affiliation
  • Bhardwaj N; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. nina.bhardwaj@mssm.edu.
  • Friedlander PA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Pavlick AC; NYU Perlmutter Cancer Center, New York, NY, USA.
  • Ernstoff MS; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Gastman BR; Cleveland Clinic, Cleveland, OH, USA.
  • Hanks BA; Duke University Medical Center, Durham, NC, USA.
  • Curti BD; Providence Portland Medical Center, Portland, OR, USA.
  • Albertini MR; University of Wisconsin, Madison, WI, USA.
  • Luke JJ; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
  • Blazquez AB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Balan S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bedognetti D; Sidra Medicine, Doha, Qatar.
  • Beechem JM; NanoString Technologies, Seattle, WA, USA.
  • Crocker AS; Celldex Therapeutics, Hampton, NJ, USA.
  • D'Amico L; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Danaher P; NanoString Technologies, Seattle, WA, USA.
  • Davis TA; Genocea Biosciences, Cambridge, MA, USA.
  • Hawthorne T; Celldex Therapeutics, Hampton, NJ, USA.
  • Hess BW; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Keler T; Celldex Therapeutics, Hampton, NJ, USA.
  • Lundgren L; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Morishima C; University of Washington, Seattle, WA, USA.
  • Ramchurren N; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Rinchai D; Sidra Medicine, Doha, Qatar.
  • Salazar AM; Oncovir, Inc., Washington, DC, USA.
  • Salim BA; Axio Research, Seattle, WA, USA.
  • Sharon E; National Institutes of Health, Bethesda, MD, USA.
  • Vitale LA; Celldex Therapeutics, Hampton, NJ, USA.
  • Wang E; Sidra Medicine, Doha, Qatar.
  • Warren S; NanoString Technologies, Seattle, WA, USA.
  • Yellin MJ; Celldex Therapeutics, Hampton, NJ, USA.
  • Disis ML; University of Washington, Seattle, WA, USA.
  • Cheever MA; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Fling SP; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. sfling@fredhutch.org.
Nat Cancer ; 1(12): 1204-1217, 2020 12.
Article in En | MEDLINE | ID: mdl-35121932
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Melanoma Type of study: Clinical_trials Limits: Humans Language: En Journal: Nat Cancer Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Melanoma Type of study: Clinical_trials Limits: Humans Language: En Journal: Nat Cancer Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido